Real-time enrollment status for this vitiligo clinical trial
Current Status
Recruiting
Checked: October 9, 2026 at 8:53 PM UTC
| NCT Number | NCT06625177 |
| Recruiting Status | Recruiting |
| Condition | Vitiligo |
| Phase | PHASE1 |
| Target Enrollment | 66 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Teva Branded Pharmaceutical Products R&D LLC |
| Last Updated on CT.gov | October 9, 2026 (20 hours ago) |
As of October 9, 2026: Clinical trial NCT06625177 is currently recruiting participants. This phase1 study for vitiligo is actively seeking new participants at 13 locations across the United States. The study is sponsored by Teva Branded Pharmaceutical Products R&D LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06625177 is actively recruiting participants as of October 9, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06625177 was last updated 20 hours ago (October 9, 2026). HelloStudys verifies this status automatically.